News Minimalist logo

GLP-1 agonists like Ozempic lower cancer risks in study

ScienceAlert — July 8, 2024, 04:00 AM UTC

Summary: A study in JAMA suggests GLP-1 agonists, including Ozempic, reduce the risk of certain obesity-related cancers. Patients with Type 2 diabetes on these drugs had significantly lower risks of 10 out of 13 cancers studied. GLP-1 agonists like Ozempic may break the link between obesity and cancer. This could lead to more doctors prescribing these drugs over insulin for diabetes treatment.

Full article

Article metrics

The article metrics are deprecated.

I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.

Timeline:

  1. [3.2]
    Weight loss drugs may enhance brain health in diabetes (Gizmodo)
    55d 0h
    Source
  2. [4.5]
    GLP-1 drugs offer benefits beyond obesity and diabetes (News-Medical.Net)
    55d 6h
    Source
  3. [3.3]
    Dr. Daniel Drucker discusses future of Ozempic-like drugs (New York Post )
    59d 22h
    Source
  4. [4.0]
    Semaglutide not linked to higher neuropsychiatric risks in T2DM (News-Medical.Net)
    61d 6h
    Source
  5. [2.7]
    Oral semaglutide matches DPP-4i in T2D adherence, persistence (News-Medical.Net)
    62d 13h
    Source
  6. [4.6]
    Ozempic linked to cognitive benefits in diabetes patients (PMLiVE)
    63d 5h
    Source
  7. [3.2]
    AI analysis of Reddit shows interest in GLP-1 drugs for weight loss and mental health benefits (News-Medical.Net)
    63d 15h
    Source
  8. [2.5]
    Semaglutide may pose risk of vision loss: Study urges caution (Business Standard)
    64d 12h
    Source
  9. [4.7]
    Ozempic improves heart and kidney health for diabetes patients (Sydney Morning Herald)
    65d 8h
    Source
  10. [4.9]
    Semaglutide (Ozempic) may reduce dementia risk and nicotine cravings (Neuroscience News)
    65d 20h
    Source
  11. [3.2]
    Ozempic linked to lower dementia risk, nicotine use - study (The Straits Times)
    65d 23h
    Source
  12. [3.2]
    Ozempic linked to lower dementia risk, nicotine use in study (The Globe and Mail)
    65d 23h
    Source
  13. [3.9]
    Antidiabetic drugs linked to lower dementia risk in T2DM (News-Medical.Net)
    66d 0h
    Source
  14. [4.0]
    Ozempic linked to lower dementia rate in Oxford study (BNN Bloomberg)
    66d 8h
    Source
  15. [3.5]
    Ozempic and similar drugs may lower cancer risks (Forbes Australia)
    66d 13h
    Source
  16. [3.3]
    GLP-1 agonists lower dementia risk for diabetes patients (PsyPost)
    66d 16h
    Source
  17. [3.9]
    Weight-loss jabs lower cancer risk compared to insulin - study (The Conversation)
    67d 1h
    Source
  18. [4.7]
    GLP-1 agonists reduce cancer risk in type 2 diabetes (Inside Precision Medicine)
    68d 1h
    Source
  19. [3.4]
    GLP-1s reduce cancer risk in type 2 diabetes patients (PMLiVE)
    68d 5h
    Source
  20. [3.9]
    GLP-1 drugs linked to lower cancer risks in diabetes patients (Ars Technica)
    69d 1h
    Source
  21. [3.5]
    Semaglutide linked to rare eye disease causing vision loss (ScienceAlert)
    69d 6h
    Source
  22. [2.2]
    Semaglutide linked to higher risk of NAION in study (The Express Tribune)
    70d 4h
    Source
  23. [2.5]
    Semaglutide (Ozempic) linked to increased risk of blindness (Insight)
    70d 13h
    Source
  24. [5.3]
    GLP-1 meds like Ozempic, Wegovy may lower cancer risk (CTV News)
    71d 3h

    ScoresSource
  25. [4.4]
    GLP-1 diabetes drugs reduce cancer risk, study finds (The Manila Times)
    72d 1h
    Source
  26. [5.0]
    GLP-1 medications may lower risk of certain cancers (CNN)
    72d 16h

    ScoresSource
  27. [2.2]
    GLP-1s lower risk of 10 obesity-related cancers in diabetes (Medpage Today)
    72d 20h
    Source
  28. [5.2]
    GLP-1 drugs like Ozempic may reduce cancer risk (Quartz)
    72d 21h

    ScoresSource
  29. [5.1]
    GLP-1 treatments reduce cancer risk in diabetes patients (GMA News Online)
    72d 22h

    ScoresSource
  30. [5.1]
    GLP-1 drugs reduce cancer risks for diabetes patients (Finimize)
    73d 1h

    ScoresSource
  31. [1.3]
    Weight loss drugs linked to rare eye condition risk (India TV News)
    73d 13h
    Source
  32. [2.9]
    Weight-loss drugs may increase risk of rare blindness (Firstpost)
    74d 5h
    Source
  33. [3.2]
    Novo Nordisk weight loss drugs linked to rare eye condition (CNBC)
    74d 7h
    Source
  34. [3.3]
    Ozempic linked to rare blindness cases in study (Business Insider)
    74d 23h
    Source
  35. [3.2]
    Wegovy, Ozempic linked to sight-threatening eye disorder in study (GMA News Online)
    75d 1h
    Source
  36. [3.4]
    Weight loss and diabetes drugs linked to rare blindness risk (CNN)
    75d 2h
    Source
  37. [3.2]
    Weight-loss jabs linked to potential blindness risk in study (The Guardian)
    75d 2h
    Source